We are pleased to say that ID-IRI study analyzing neuroinvasive West Nile virus infections is provisionally accepted for publication in the Journal of Clinical Virology. The journal asks for minor revision. Thanks to the Roman team, Dr. Corneliu Popescu and Simin Aysel Florescu in particular, in finalizing the entire process and many thanks to the ID-IRI platform.
Corneliu Petru Popescu, Simin Aysel Florescu, Rodrigo Hasbun, Arjan Harxhi, Razi Evendar, Hasip Kahraman, Ami Neuberger, Daniel Codreanu, Mihaela Florentina Zaharia, Selma Tosun, Emanoil Ceausu, Simona Maria Ruta, Gorana Dragovac, Natalia Pshenichnaya, Galina Gopatsa, Olga Shmaylenko, Éva Nagy, Jelena Djekic Malbasa, Mirjana Strbac, Nenad Pandak, Husnu Pullukcu, Botond Lokotos, Yasemin Cag, Antonio Cascio, Ilaria Coledan, Serkan Oncu, Hakan Erdem
ID-IRI study “Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study” is published online in European Journal of Clinical Microbiology and Infectious Diseases. Thanks to all participants. Please see the link below
We have previously announced ID-IRI survey targeting MDR organisms, IPC and antibiotic stewardship issues. It is to start within a couple of weeks for your information. The study will focus on
1. Antibiotic susceptibility profiles of infecting pathogens
2. Infection Prevention & Control capabilities
3. Antibiotic stewardship infrastructure
We will send the application form to sign and return the scanned document to us via email.
The complete list of participants in VbZ infections survey can be seen at our website.
Some of the centers have agreed participation although they did not submit the cases applied to their hospitals in the study week. Below is the study protocol we have sent to participating centers. We only included participants who submitted patients’ data FYI. If you have any questions, you can contact me. Many thanks for your contributions.
All the best
We are about to finalize the manuscript of West Nile Virus neuroinvasive disease ID-IRI study. Currently we are at the final check stage. We are planning to send the draft of the paper to participants within a couple weeks FYI.
We have analyzed 165 WNV CNS infections in this study. Hence this is a huge cohort. Many thanks to our group.
ID-IRI study analyzing infective endocarditis has been accepted for publication in European Journal of Clinical Microbiology & Infectious Diseases. The data came from referral centers in 13 countries.
The idea behind this survey was to provide one of the largest patient databases ever provided in the literature and to picture the current status of endocardial infections as a snapshot tool. To prevent confusion and to provide more robust data we excluded probable endocarditis patients and included definitive endocarditis patients solely. On the whole, we analyzed 867 cases with definitive endocarditis and we believe this is a huge number.
The paper delineates in detail the epidemiology/microbiology/histopathology of infective endocarditis, the extents and types of complications particularly the embolic patterns and suppurative complications, underlying disorders with special emphasis on cardiac parameters, the differences between PVE and NVE cases. Furthermore, the manuscript also mentions outcome parameters. Finally, we wanted to delineate the impacts and contributions of diagnostic parameters (Vascular and immunological phenomena, microbiological or radiological data) in due course of diagnostic courses.
We hope that this study will provide a general understanding of infective endocarditis and will help decision making by optimizing clinical approaches both to infectious diseases physicians and the cardiologists worldwide with its current presentation. As you kindly appreciate robust inferences could only be made through huge patient databases. Thanks to the contributors once again.
ID-IRI Vector-borne and zoonotic infections survey is about to start within a couple of weeks. The design of the study will be prospective and cross-sectional.
We are still open to centers eager to join us, We will not be able to include additional Turkish centers since we previously noted counterparts from Turkey.
Those willing to join the study can kindly contact Dr Nurhayat Bayazıt.
Contact point: firstname.lastname@example.org